Menu

Javascript is not activated in your browser. This website needs javascript activated to work properly.
You are here

Working Groups

Our overarching research goal is to create new and innovative strategies for improved and novel treatments, disease modification and eventually cures for neurodegenerative diseases. We are striving to understand the mechanisms of neurodegenerative diseases, and to create a dynamic structure for the advancement of research, innovation and education in the field. Ultimately, our research will improve functioning, health and quality of life of people living and ageing with these diseases.

In order to reach this goal, we aim to:

  1. Determine molecular and cellular mechanisms of pathogenesis in neurodegenerative disease
  2. Perform pioneering transplantation trials using stem cells
  3. Perform clinical trials using gene-transfer based therapy
  4. Develop new pharmacological approaches for disease-modifying and symptomatic therapies
  5. Perform leading translational research on cognitive dysfunction and other non-motor symptoms
  6. Develop and implement accurate biomarker and imaging tools for diagnostic purposes and outcome measures
  7. Develop, test and evaluate new health promoting interventions

For the redefined aims, translational working groups have been formed, with the following mission:
Benchmark progress, define milestones and deliverables for each aim - in terms of competitive science.


The translational working groups are the following:

1. Determine molecular and cellular mechanisms of pathogenesis in neurodegenerative disease (adressing aim 1)

Convening members:
Gunnar Gouras
Jia-Yi Li


2. Perform Pioneering Transplantation Trials Using Stem Cells (adressing aim 2)

Convening members:  
Malin Parmar  
Håkan Widner


3. Gene Therapy (addressing aim 3)

Convening members:  
Johan Jakobsson
Cecilia Lundberg


4. Develop New Pharmacological Approaches for Disease-Modifying and Symptomatic Therapies (addressing aim 4)

Convening members:  
Angela Cenci Nilsson  
Per Odin


5. Perform Leading Translational Research on Cognitive Dysfunction and other Non-Motor Symptoms (addressing aim 5)

Convening members:
Sebastian Palmqvist
Gunnar Gouras


6. Biomarker and Bio-imaging (addressing aim 6)

Convening members:  
Oskar Hansson (Clinical PET) 
Deniz Kirik (Pre-clinical PET and MRI)


7. Outcome Measures (addressing aim 7)

Convening members:
Maria H Nilsson
Jan Lexell

Page Manager:

Lund University 
MultiPark
Sölvegatan 19
SE-221 84 Lund